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Abstract
Background: Ambulatory blood pressure monitoring (ABPM) is increasingly used to measure blood pressure (BP)
in research studies. We examined ease of use, comfort, degree of disturbance, reported adverse effects, factors
associated with poor tolerability, and association of poor tolerability with data acquisition of 24-hour ABPM using
the Oscar 2 monitor in the research setting.
Methods: Sixty adults participating in a research study of people with a history of borderline clinic BP reported on
their experience with ABPM on two occasions one week apart. Poor tolerability was operationalized as an overall
score at or above the 75th percentile using responses to questions adapted from a previously developed
questionnaire. In addition to descriptive statistics (means for responses to Likert-scaled “0 to 10” questions and
proportions for Yes/No questions), we examined reproducibility of poor tolerability as well as associations with
poor tolerability and whether poor tolerability was associated with removal of the monitor or inadequate number
of BP measurements.
Results: The mean ambulatory BP of participants by an initial ABPM session was 148/87 mm Hg. After wearing the
monitor the first time, the degree to which the monitor was felt to be cumbersome ranged from a mean of 3.0 to
3.8, depending on whether at work, home, driving, or other times. The most bother was interference with normal
sleeping pattern (mean 4.2). Wearers found the monitor straightforward to use (mean 7.5). Nearly 67% reported
that the monitor woke them after falling asleep, and 8.6% removed it at some point during the night. Reported
adverse effects included pain (32%), skin irritation (37%), and bruising (7%). Those categorized as having poor
tolerability (kappa = 0.5 between sessions, p = 0.0003) were more likely to report being in fair/poor health (75% vs
22%, p = 0.01) and have elevated 24-hour BP average (systolic: 28% vs 17%, p = 0.56; diastolic: 30% vs 17%, p =
0.37). They were also more likely to remove the monitor and have inadequate numbers of measurements.
Conclusions: The Oscar 2 ABPM device is straightforward to use but can interfere with sleep. Commonly reported
adverse effects include pain, skin irritation, and bruising. Those who tolerate the monitor poorly are more likely to
report being in fair or poor health and to remove it, particularly at night.
Background
The evidence for the clinical utility of ambulatory blood
pressure monitoring (ABPM) continues to accumulate.
Blood pressure (BP) measured by this technique is more
closely associated with prognosis and is considered to
be the current gold standard method for determining an
individual’s true BP [1,2]. Clinically, ambulatory BP
monitoring is valuable for confirming suspected white-
coat hypertension or evaluating white-coat effect in
patients with apparently difficult-to-control hyperten-
sion, for detecting masked hypertension, and for gaining
a better estimate of BP control among treated patients
[2-4]. Additionally, ABPM is useful when evaluating
symptoms possibly due to hypotension and is the only
technique currently available to assess night-time (sleep)
BP [2]. In addition to its clinical usefulness, ambulatory
BP monitoring is now recognized as critical in studies of
BP-lowering treatments [5].
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An obvious downside of ambulatory BP monitoring is
the potential inconvenience, related to the need to keep
the cuff on the arm during the entire measurement per-
iod (usually 24 hours) as well as having to wear the
monitor unit on the waist (by a belt or strap) during the
day and keep it at the bedside at night. It is thus impor-
tant to have some sense of the individual’s experience
when undergoing ambulatory BP monitoring. The Oscar
2 (SunTech Medical, Morrisville, NC) ambulatory BP
monitor, in addition to being light and compact, uses
motion tolerant algorithms to reduce re-inflates and
failed readings. It has an additional feature (auto-intelli-
gent inflation pressure) designed to reduce measurement
time and reduce patient discomfort by controlling cuff
inflation. A special cuff (the Orbit cuff) has a stretch-
sleeve designed to maintain cuff placement and promote
patient comfort. We assessed tolerability of wearing the
Oscar 2 ambulatory BP monitor among a group of
adults not yet diagnosed with hypertension who partici-
pated in a research project. A unique feature of our
study is that participants wore the monitors on two
occasions and they reported on their experiences after
each monitoring session.
Methods
This study was part of a project conducted to assess the
reproducibility of classifications of blood pressure based
on pairings of office and out-of-office measurements for
purposes of informing the design of a larger study. We
recruited sixty adults via signs inviting participation in a
study of people with a recent clinic BP measurement
that was “borderline” or “a little high.” Signs were
posted in an academic family medicine center, two com-
munity family medicine practices and in a clinical
research center. Individuals interested in participating
contacted a study coordinator to confirm eligibility and
schedule their study visits. To be eligible, a person had
to be 30 years of age or older (although one person who
was actually 29 years old ended up being enrolled), have
no diagnosis of hypertension and be on no medications
to lower BP. Exclusion criteria included pregnancy,
dementia, any condition that would preclude wearing
the monitor (including an arm circumference >46 cm),
and persistent atrial fibrillation or other arrhythmia. As
an incentive, participants were offered $150 for comple-
tion of the study.
Informed consent was obtained prior to any study
procedures. Participants underwent two 24-hour ambu-
latory BP monitoring sessions one week apart using the
Oscar 2 oscillometric monitor. The Oscar 2 has been
validated for use in adults by both the British Hyperten-
sion Society protocol and the International Protocol for
the validation of blood pressure measuring devices [6,7].
The monitors were programmed to measure BP at 30
minute intervals during the daytime (6 am to 11 pm)
and at 1 hour intervals during the nighttime (11 pm to
6 am). Maximum BP measurement time was limited to
less than 140 seconds, and the monitors were set for a
maximum pressure of 220 mm Hg. Participants were
given verbal instructions on wearing the monitor,
including that that they should try to leave the cuff on
during the entire monitoring period, that they should
try to hold their cuffed arm as still as possible during a
reading to ensure that the monitor would get an accu-
rate reading, that cuff inflation would cause a tight feel-
ing around the arm, and that faulty readings would
trigger a repeat measurement. Following each monitor-
ing session, participants completed a questionnaire to
assess tolerability of wearing the monitor (Appendix).
This questionnaire was adapted from one used in a pre-
vious study designed to assess patient satisfaction with
wearing an ambulatory BP monitor [8].
We report responses to Likert-scaled questions as
means with standard deviations and responses to cate-
gorical questions as percentages. We created an overall
tolerability score as the sum of the responses to ques-
tions 1 and 4 through 8 minus the responses to ques-
tions 2 and 3. We defined poor tolerability as a total
score of Likert-scaled responses at or above the 75th
percentile of the sample. We examined agreement on
poor tolerability between the first and second sessions
of wearing the monitor and calculated the kappa coeffi-
cient and its p-value. We then examined bivariate asso-
ciations of demographic and general health
characteristics with poor tolerability at first wearing of
the monitor and tested for significance using chi-square.
Finally, we examined whether poor tolerability was asso-
ciated with reported removal of the monitor and inade-
quate number of BP measurements. Inadequate number
of measurements was defined as <14 usable readings for
daytime and <7 usable readings fro nighttime. This
study was approved by the Office of Human Research
Ethics at the University of North Carolina.
Results
Participant characteristics
The mean (±SD) age of the sixty participants was 47.6
(±10.5). Most participants were between 45 and 64 years
(56.7%) or between 29 and 44 years (36.7%) (Table 1). A
small proportion was older than 65 years (6.7%). Slightly
more than half were female. Approximately 57% were
white, and 40% were Black. Few were of Hispanic ethni-
city. Over half were college graduates, and the majority
(91.7%) reported good to excellent health. Most (83.3%)
were also nonsmokers and overweight (25.0%) or obese
(56.7%). Approximately two-thirds were married or living
with a partner. Everyone who enrolled in the study com-
pleted it, although not everyone provided complete data.
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The sample mean of the average 24-hour ambulatory BPs
of participants was 148/87 mm Hg from the first sessions
and 146/85 mm Hg from the second sessions.
Monitor comfort, ease of use, and bother
After wearing the monitor the first time, the extent to
which people found the monitor heavy was minimal, as
indicated by a mean score of 1.4 on the 0 to 10 scale
(Table 2). Wearers generally found the monitor straight-
forward to use (mean 7.5). However, the comfort of the
monitor was not rated as favorably, with a mean score
of 3.9. The degree to which the monitor was
cumbersome to wear ranged from a mean of 3.0 to 3.8,
depending on the location. The noise of the pump was
not much of a bother to the wearer (mean ranged from
1.3 to 2.3 depending on location) or to others (mean
2.3). The most bother was due to interference with the
normal sleeping pattern (mean 4.2). There was little
change in mean responses from first to second wearing
of the monitor. The only exceptions were that the
extent to which the monitor was straightforward to use
increased to 8.4 (p = 0.06), and it was rated slightly
more embarrassing (mean 1.7 to 2.2, p = 0.04) and
slightly more cumbersome to wear at work (mean 3.1 to
3.8, p = 0.06) during the second monitoring session.
Adverse effects and outcomes of monitor wear
After wearing the monitor the first time, 19.6% reported
that it stopped them from falling asleep, and 70.2%
reported that the monitor awakened them from sleep
(Table 3), with 8.8% reporting that the monitor dis-
turbed them enough to make them remove it during the
night. Fewer reported that the monitor disturbed them
enough to make them remove it at some point during
the day (5.1% and 8.5%). Nearly one out of three wear-
ers reported pain from wearing the monitor, and 39.0%
experienced skin irritation after first-wear with a slight
Table 1 Participant characteristics (N = 60)
Characteristic n Percent* Mean (SD)
Age group (years)
29-44 22 36.7
45-64 34 56.7
>65 4 6.7
Female sex 31 51.7
Race
Black 24 40.0
White 34 56.7
Other 2 3.3
Hispanic ethnicity 2 3.3
Education level
Some high school 2 3.3
High school graduate 3 5.0
Some college 21 35.0
College graduate 34 56.7
Self-reported health
Excellent 10 16.7
Very good 29 48.3
Good 16 26.7
Fair or poor 5 8.3
Nonsmoker 50 83.3
BMI
Normal (<25 kg/m2) 11 18.3
Overweight (25-29 kg/m2) 15 25.0
Obese (≥30 kg/m2) 34 56.7
Arm circumference**
<35 cm 36 72.0
≥35 cm 14 28.0
Married or living with partner**
Yes 35 65.0
No 15 35.0
24-hour systolic BP, mm Hg (1st time) 148 (14)
24-hour diastolic BP, mm Hg (1st time) 87 (10)
24-hour systolic BP, mm Hg (2nd time) 146 (14)
24-hour diastolic BP, mm Hg (2nd time) 85 (10)
BMI, body mass index.
*Some percentages do not add exactly to 100 due to rounding.
** missing data on 10 participants.
Table 2 Monitor comfort, ease of use, and degree of
bother
Mean (SD)
after 1st
session
Mean (SD)
after 2nd
session
p-value*
Found monitor heavy 1.4 (2.1) 1.4 (1.9) 0.94
Found monitor
comfortable
3.9 (2.5) 3.8 (2.3) 0.93
Found monitor
straightforward to use
7.5 (3.2) 8.4 (2.8) 0.06
Found monitor
cumbersome to wear...
At home 3.8 (3.0) 3.9 (2.8) 0.97
At work 3.1 (2.8) 3.8 (2.9) 0.06
Driving 3.6 (2.9) 3.8 (2.9) 0.35
Other times 3.8 (2.9) 3.5 (2.7) 0.47
Noise of the pump
disturbed [me]...
At home 2.3 (2.5) 2.2 (2.6) 0.82
At work 2.2 (2.7) 2.6 (2.8) 0.14
Driving 1.3 (1.7) 1.6 (2.4) 0.34
Other times 1.9 (2.2) 2.3 (2.6) 0.23
Noise of the pump
disturbed others
2.3 (2.5) 2.3 (2.6) 0.81
Found monitor
embarrassing to wear
1.7 (2.8) 2.2 (3.0) 0.04
Monitor interfered with
normal sleeping pattern
4.2 (3.3) 4.3 (3.5) 0.84
*P-value by paired t-test with two-sided alpha.
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increase (45.8%) at second wear. After first wearing the
monitor, 6.8% reported experiencing bruising. After
wearing the monitor the second time, though, 20.3%
reported bruising.
Poor tolerability and data acquisition
People categorized as having poor tolerability to wearing
the monitor based on their responses to the Likert-
scaled questions were largely the same at both monitor-
ing sessions, with 82% agreement (kappa = 0.6, p =
0.0001). Among people who reported fair/poor health,
75% tolerated the monitor poorly, but among the parti-
cipants reporting good to excellent health, 22.2% toler-
ated the monitor poorly (p = 0.01) (Table 4). Though
not statistically significant, those with higher 24-hour
BP also tended to tolerate the monitor more poorly. A
higher proportion of participants categorized as having
poor tolerability removed the monitor during the day
during the first wear (7.7% vs 2.8%) and the second
wear (14.3% vs 5.0%) (Table 5). However, neither of
these differences were statistically significant (p = 0.44
and p = 0.25, respectively). A higher proportion of parti-
cipants categorized as having poor tolerability removed
the monitor during the night (15.4% vs 2.9%, p = 0.11)
during the first wear, and a significantly higher propor-
tion of participants categorized as having poor tolerabil-
ity removed the monitor during the night (28.6% vs
2.5%, p = 0.004) during the second wear.
At the first monitoring session the number of ambula-
tory BP measurements during daytime wear was inade-
quate among 15.4% of participants categorized as having
poor tolerability and 2.8% (p = 0.10) among those not
categorized as such (Table 5). The percent of participants
with inadequate measurements over the entire 24-hours
during the first monitoring session was similar between
the two groups. At the second monitoring, however, the
percents of participants with inadequate measurements
during daytime wear were 21.4% vs 2.5% (p = 0.02) and
over 24-hours were 50.0% vs 22.5% (p = 0.05).
Discussion
Overall, participants in this study seemed to have little
difficulty with using the Oscar 2 ambulatory BP
Table 3 Outcomes and adverse effects of monitor wear
Percent
after 1st
session
Percent
after 2nd
session
p-
value*
Monitor stopped me from falling
asleep
19.6 16.1 0.48
Monitor woke me up after falling
asleep
70.2 64.9 0.41
Monitor disturbed me sufficiently
to make me remove it during the
day
5.1 8.5 0.32
Monitor disturbed me sufficiently
to make me remove it during the
night
8.8 8.8 1.0
Experienced pain from wearing
the monitor
33.9 35.6 0.76
Experienced skin irritation from
wearing the monitor
39.0 45.8 0.35
Experienced bruising from
wearing the monitor
6.8 20.3 0.02
*P-value by McNemar’s chi square test
Table 4 Associations with poor tolerability to wearing
monitor
Characteristic Percent p-value*
Age group (years) 0.27
29-44 38.9
45-64 20.1
>65 0
Sex 0.81
Male 25.0
Female 28.0
Race 0.73
Black 30.4
White 24.0
Other 0
Education level 0.53
Some high school 0
High school graduate 0
Some college 26.3
College graduate 32.0
Self-reported health
Excellent, very good, good 22.2 0.01
Fair/poor 75.0
Smoker 0.98
Yes 25.0
No 24.4
BMI 0.36
Normal (<25 kg/m2) 36.4
Overweight (25-29 kg/m2) 13.3
Obese ( ≥30 kg/m2) 30.4
Arm circumference 0.47
<35 cm 23.5
≥35 cm 33.3
Married or living with partner
Yes 21.9 0.31
No 35.3
24-hour systolic BP ≥ 130 mm Hg 0.56
Yes 27.9
No 16.7
24-hour diastolic BP ≥ 80 mm Hg 0.37
Yes 29.7
No 16.7
BMI, body mass index
*P-value by chi-square
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monitor. As has been found in other studies of tolerabil-
ity of ambulatory BP monitoring, the greatest distur-
bance from wearing the monitor was interference with
sleep [9-11]. Two-thirds of wearers reported that the
monitor awakened them from sleep. Nonetheless, most
participants continued to wear the monitor at night. We
found no studies with which to make a direct compari-
son about the proportion of participants who reported
actually removing the monitor. Our questions about
monitor removal were modified from a prior study’s
questionnaire [8], and we found no other study contain-
ing similar items. In that study of pregnant women
undergoing ABPM using a SpaceLabs 90207 (SpaceLabs
Medical, Inc, Redmond, WA) monitor, 15% discontin-
ued their monitoring session [8]. However, the results
may not be comparable to ours due to the different
population and the slightly different questions used.
We found that the most commonly reported adverse
physical effects were pain and skin irritation. Bruising
was also reported, although less frequently. It is possible
that the second monitoring session resulted in more
bruising because it occurred so shortly after the first
session. The proportion of participants with inadequate
ambulatory BP data was also higher data at the second
monitoring. While there may be a need for ambulatory
BP monitoring on consecutive weeks in research studies,
it is less likely to be used in this manner for clinical
care. Other studies have found that approximately 90 to
95% of patients undergoing ambulatory BP monitoring
for clinical reasons would be willing to have a repeat
monitoring session if so advised [10,12].
Not surprisingly, we found that people with poor toler-
ability to wearing the monitor were more likely to
remove it, particularly during sleep. However, at the first
monitoring session, 24-hour data acquisition was ade-
quate in nearly three-fourths of the participants regard-
less of whether classified as having poor tolerability or
not. This information can be useful for investigators
planning research studies. It may be difficult to know
who will tolerate the monitor poorly, but we did find that
people whose self-reported health status was fair or poor
were more likely to be categorized as having poor toler-
ability. However, this may simply reflect a “rating bias”
whereby people who rate their health negatively may rate
everything negatively. Our study also may overestimate
true tolerability since our sample consisted of voluntary
participants in a research study who received monetary
incentive for wearing the monitor on two occasions.
To our knowledge, this is the first study to examine
the tolerability of ambulatory BP monitoring using the
Oscar 2 monitor with its specially designed Orbit cuff.
Adverse effects of wearing this monitor seem similar to
those described with other monitors. In a study of
acceptability of wearing the Mobil-O-Graph (IEM
GmbH, Stolberg, Germany) oscillometric ambulatory BP
monitor, 55% of patients reported interference with
sleep, 41% reported pain, and 17% had a local skin reac-
tion [12]. In an examination of acceptance of ambula-
tory monitoring using a SpaceLabs 90207 device, 20% of
patients reported that the session was uncomfortable
[13]. Other studies of the SpaceLab 90202 device found
that 30% to 36% reported disturbed sleep, up to 20%
reported pain, and 19% to 34% reported that monitoring
disturbed their activities [9,14].
Another strength of this study is its assessment of tol-
erability on two occasions, providing some estimate of
the reproducibility of a questionnaire designed to mea-
sure people’s experience with wearing an ambulatory BP
monitor. We are aware of no other study that has done
this type of evaluation. Perhaps most importantly, we
analyzed the effects of tolerability on the number of
measurements one can expect to obtain from studies of
participants in which ambulatory BP monitoring is used.
We believe this is useful information for researchers as
well as clinicians who use ambulatory BP monitoring.
Our study is limited by a small sample size. It is likely
that some of the factors we examined (e.g., elevated BP,
greater arm circumference) would be statistically signifi-
cant with a larger sample. Additionally, because this
study was of research participants who volunteered (and
were paid) to participate, the findings may not be gener-
alizable outside the research setting. Tolerability was
also based on people’s self reports, and reported side
effects (e.g., bruising) were not verified objectively.
Conclusions
Despite the above limitations, it is clear that ambulatory
BP monitoring using current devices, including the
Table 5 Associations of poor tolerability with removal of
monitor and inadequate data acquisition
Poor tolerability to
wearing monitor
Yes
(%)
No
(%)
p-
value
Day removal, first wearing 7.7 2.8 0.44
Night removal, first wearing 15.4 2.9 0.11
Day removal, second wearing 14.3 5.0 0.25
Night removal, second wearing 28.6 2.5 0.004
Inadequate data for daytime, first wearing 15.4 2.8 0.10
Inadequate data for nighttime, first wearing 23.1 19.4 0.78
Inadequate data for entire 24 hours, first
wearing
23.1 19.4 0.78
Inadequate data for daytime, second wearing 21.4 2.5 0.02
Inadequate data for nighttime, second
wearing
42.9 22.5 0.14
Inadequate data for entire 24 hours, second
wearing
50.0 22.5 0.05
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Oscar 2 monitor, is not a procedure without some
inconveniences and some minor transient adverse
effects. It thus does not come as a surprise that ambula-
tory monitoring has been found to be the least patient-
preferred method of measuring BP (after home monitor-
ing and office measurement) [15]. However, studies
show that patients also can appreciate the value of the
information provided by ambulatory BP monitoring
[13]. The data on potential adverse effects as well as the
likelihood of disturbances of activities (especially sleep)
should be explained to research subjects (or patients)
along with the importance of the blood pressure infor-
mation to be obtained from ambulatory BP monitoring
so that people undergoing monitoring understand both
the risks and benefits.
Appendix - Questionnaire
POST-AMBULATORY BP MONITORING
QUESTIONNAIRE
For the following questions, please circle the answer
that corresponds to your response on a scale from 0
to 10:
0 = “Not at all" 5 = “Somewhat" 10 =
“Extremely”
1. Did you find the monitor heavy?
0 1 2 3 4 5 6 7 8 9 10
2. Did you find the monitor comfortable to wear?
0 1 2 3 4 5 6 7 8 9 10
3. Did you find the monitor straightforward to use?
0 1 2 3 4 5 6 7 8 9 10
4. Did you find the monitor cumbersome to wear...
At home?
0 1 2 3 4 5 6 7 8 9 10
At work?
0 1 2 3 4 5 6 7 8 9 10
Driving?
0 1 2 3 4 5 6 7 8 9 10
At other times?
0 1 2 3 4 5 6 7 8 9 10
5. Did the noise of the pump disturb you...
At home?
0 1 2 3 4 5 6 7 8 9 10
At work?
0 1 2 3 4 5 6 7 8 9 10
Driving?
0 1 2 3 4 5 6 7 8 9 10
At other times?
0 1 2 3 4 5 6 7 8 9 10
6. Did the noise of the pump disturb others?
0 1 2 3 4 5 6 7 8 9 10
7. Did you find the monitor embarrassing to wear?
0 1 2 3 4 5 6 7 8 9 10
8. Did you find the monitor interfered with your
normal sleeping pattern?
0 1 2 3 4 5 6 7 8 9 10
Please circle your response to the next questions.
9. If your sleep was disturbed, did the monitor stop
you from falling asleep?
Yes No Sleep was not disturbed
10. If your sleep was disturbed, did the monitor
wake you up after you had fallen asleep?
Yes No Sleep was not disturbed
11. Did the monitor disturb you sufficiently to
make you remove it during the day?
Yes No
12. Did the monitor disturb you sufficiently to
make you remove it during the night?
Yes No
13. Did you experience pain from wearing the
monitor?
Yes No
14. Did you experience skin irritation from wearing
the monitor?
Yes No
15. Did you experience bruising from wearing the
monitor?
Yes No
THANK YOU FOR COMPLETING THIS
QUESTIONNAIRE!
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